- Home
- BEEM vs ESLA Comparison
BEEM vs ESLA Comparison
Compare BEEM & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEEM
- ESLA
- Stock Information
- Founded
- BEEM 2006
- ESLA 2021
- Country
- BEEM United States
- ESLA United States
- Employees
- BEEM N/A
- ESLA N/A
- Industry
- BEEM Semiconductors
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BEEM Technology
- ESLA Health Care
- Exchange
- BEEM Nasdaq
- ESLA Nasdaq
- Market Cap
- BEEM 49.3M
- ESLA 41.6M
- IPO Year
- BEEM N/A
- ESLA N/A
- Fundamental
- Price
- BEEM $3.03
- ESLA $1.18
- Analyst Decision
- BEEM Strong Buy
- ESLA
- Analyst Count
- BEEM 4
- ESLA 0
- Target Price
- BEEM $9.00
- ESLA N/A
- AVG Volume (30 Days)
- BEEM 362.7K
- ESLA 17.0K
- Earning Date
- BEEM 11-14-2024
- ESLA 02-12-2025
- Dividend Yield
- BEEM N/A
- ESLA N/A
- EPS Growth
- BEEM N/A
- ESLA N/A
- EPS
- BEEM N/A
- ESLA N/A
- Revenue
- BEEM $60,883,000.00
- ESLA N/A
- Revenue This Year
- BEEM N/A
- ESLA N/A
- Revenue Next Year
- BEEM $24.12
- ESLA N/A
- P/E Ratio
- BEEM N/A
- ESLA N/A
- Revenue Growth
- BEEM 10.25
- ESLA N/A
- 52 Week Low
- BEEM $2.62
- ESLA $0.63
- 52 Week High
- BEEM $8.48
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- BEEM 43.75
- ESLA 51.64
- Support Level
- BEEM $2.92
- ESLA $1.05
- Resistance Level
- BEEM $3.31
- ESLA $1.27
- Average True Range (ATR)
- BEEM 0.34
- ESLA 0.15
- MACD
- BEEM 0.00
- ESLA -0.01
- Stochastic Oscillator
- BEEM 10.28
- ESLA 53.33
About BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.